Ami Organics rises 28% in one month; JM Financials initiates ‘buy’, eyes 19% returns at ₹1,965 TP; 5 key reasons
Ami Organics' strength in R&D and manufacturing large-scale pharma intermediates will help it increase the contract revenue share in its pharma intermediates business and provide long-term sales visibility.